Global Molecular Diagnostics Market Worth $8.1 Billion by 2017

Global Molecular Diagnostics Market Worth $8.1 Billion by 2017 PR Newswire DALLAS, October 25, 2012 DALLAS, October 25, 2012 /PRNewswire/ -- The new market research report "Molecular Diagnostics Market - Technologies [PCR, DNA Sequencing, Microarray, Transcription Mediated Amplification, Hybridization], Applications [Virology / Infectious Diseases, Cancer / Oncology, Genetic Testing, Blood Screening, Microbiology] Global Opportunities, Competitor Analysis & Forecasts to 2017" analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia, and Rest of the World. Browse 130+ market data tables / figures spread through 391 pages and in-depth TOC of "Molecular Diagnostics Market - Technologies, Applications - Global Opportunities, Competitor Analysis & Forecasts to 2017". http://www.marketsandmarkets.com/Market-Reports/molecular-diagnostic-market-833.html Early buyers will receive 10% customization on reports. This report studies the global molecular diagnostics market, with forecast to 2017. Molecular diagnostics (MDx) is a new class of diagnostic tests that identify nucleic acids or proteins to test the status of a disease. These nucleic acids or proteins, which belong to individual patients or foreign organisms, help determine a specific therapy, or risk of developing a specific disease, or other health conditions.